FindTrial
Sign In

Research on the Early Mortality Risk of Acute Myeloid Leukemia (Non-APL) Based on AI Prediction

A multicenter, real-world study on AI-based prediction of the risk of early death in non-APL acute myeloid leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102070
Enrollment
Unknown
Registered
2025-05-08
Start date
2025-05-08
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia

Interventions

Early Death Group:None

Sponsors

Ganzhou Branch of Nanfang Hospital (Ganzhou Pelple's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed acute leukemia

Exclusion criteria

Exclusion criteria: 1. Patients with Acute Promyelocytic Leukemia (APL) and Acute Lymphoblastic Leukemia (ALL) 2. Those who have not had samples retained for testing within 48 hours 3. AML patients lost to follow-up

Design outcomes

Primary

MeasureTime frame
60-day mortality;bleeding event;—

Countries

China

Contacts

Public ContactZuomiao Xiao

Ganzhou Branch of Nanfang Hospital (Ganzhou Pelple's Hospital)

ganxzmiao@163.com+86 139 7079 3252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026